TABLE 1.
Groups | SBP, mmHg | DBP, mmHg |
---|---|---|
Healthy subjects, n=45 (mean ± SD) | 118±7 | 78±7 |
Group I, n=35 (mean ± SD) | 170±8 | 103±5 |
Group II, n=30 (mean ± SD) | 144±8 | 85±6 |
Group III, n=30 (mean ± SD) | 131±9 | 84±5 |
Group comparisons | P (SBP) | P (DBP) |
Group I versus group II | <0.05 | <0.05 |
Group I versus group III | <0.005 | <0.05 |
Group II versus group III | <0.005 | >0.05 |
Healthy subjects versus group I | <0.0005 | <0.005 |
Healthy subjects versus group II | <0.0005 | <0.1 |
Healthy subjects versus group III | <0.025 | <0.1 |
Group I Post reperfusion myocardial infarction patients; Group II Post reperfusion myocardial patients receiving acetylsalicylic acid along with a beta-blocker; Group III Post reperfusion myocardial patients receiving vitamin E, acetylsalicylic acid and a beta-blocker. P>0.05 not significant